部位 | ICD-O-3 | 合計 | 男性 | 女性 | |||
---|---|---|---|---|---|---|---|
件数 | % | 件数 | % | 件数 | % | ||
全部位 | 3,230 | 100.0% | 1,724 | 100.0% | 1,506 | 100.0% | |
頭頸部 | C00-C14 C30-C32 | 222 | 6.9% | 146 | 8.5% | 76 | 5.0% |
食道 | C15 | 224 | 6.9% | 178 | 10.3% | 46 | 3.1% |
胃 | C16 | 230 | 7.1% | 167 | 9.7% | 63 | 4.2% |
大腸 | C18-C20 | 192 | 5.9% | 112 | 6.5% | 80 | 5.3% |
( 結腸 ) | C18 | 116 | 3.6% | 62 | 3.6% | 54 | 3.6% |
( 直腸S状結腸移行部、直腸) | C19-C20 | 76 | 2.4% | 50 | 2.9% | 26 | 1.7% |
膵 | C25 | 185 | 5.7% | 91 | 5.3% | 94 | 6.2% |
気管、気管支及び肺 | C33-C34 | 231 | 7.2% | 162 | 9.4% | 69 | 4.6% |
血液、骨髄 | C420-C421 | 120 | 3.7% | 74 | 4.3% | 46 | 3.1% |
乳房 | C50 | 286 | 8.9% | 2 | 0.1% | 284 | 18.9% |
子宮 | C53-C55 | 221 | 6.8% | - | - | 221 | 14.7% |
( 子宮頚 ) | C53 | 108 | 3.3% | - | - | 108 | 7.2% |
( 子宮体部 ) | C54 | 113 | 3.5% | - | - | 113 | 7.5% |
( 子宮NOS ) | C55 | 0 | 0.0% | - | - | 0 | 0.0% |
前立腺 | C61 | 205 | 6.3% | 205 | 11.9% | - | - |
髄膜、脳、脊髄、脳神経及びその他の中枢神経系 | C70-C72 | 178 | 5.5% | 79 | 4.6% | 99 | 6.6% |
悪性リンパ腫 | M959-M972 | 164 | 5.1% | 88 | 5.1% | 76 | 5.0% |
その他(100件未満) | 772 | 23.9% | 420 | 24.4% | 352 | 23.4% |
※4 登録症例が年間100例に満たないものはその他に含みます。
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 94.7% | 100.0% | 77.8% | 30.0% | 100.0% | 0.0% | 87.2% |
手術 | 37.1% | 100.0% | 77.8% | 25.0% | 8.3% | 0.0% | 38.0% |
(うち、体腔鏡的治療) | 28.8% | 33.3% | 0.0% | 5.0% | 8.3% | 0.0% | 23.5% |
内視鏡的治療 | 60.6% | 0.0% | 0.0% | 5.0% | 91.7% | 0.0% | 51.4% |
放射線療法 | 0.0% | 0.0% | 0.0% | 10.0% | 0.0% | 0.0% | 1.1% |
化学療法 | 8.3% | 66.7% | 55.6% | 70.0% | 0.0% | 0.0% | 19.0% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 100.0% | 95.9% | 88.9% | 100.0% | 60.0% | 100.0% | 0.0% | 92.3% |
手術 | 33.3% | 73.5% | 88.9% | 100.0% | 60.0% | 17.9% | 0.0% | 61.5% |
(うち、体腔鏡的治療) | 33.3% | 65.3% | 66.7% | 53.8% | 40.0% | 7.1% | 0.0% | 46.2% |
内視鏡的治療 | 66.7% | 24.5% | 0.0% | 0.0% | 0.0% | 85.7% | 0.0% | 32.5% |
放射線療法 | 0.0% | 2.0% | 22.2% | 15.4% | 6.7% | 0.0% | 0.0% | 5.1% |
化学療法 | 0.0% | 10.2% | 22.2% | 30.8% | 86.7% | 3.6% | 0.0% | 21.4% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 44.4% | 57.1% | 33.3% | 40.0% | 100.0% | 75.0% | 52.0% |
手術 | 44.4% | 57.1% | 0.0% | 20.0% | 100.0% | 75.0% | 48.0% |
(うち、体腔鏡的治療) | 18.5% | 0.0% | 0.0% | 0.0% | 25.0% | 0.0% | 12.0% |
内視鏡的治療 | 0.0% | 0.0% | 33.3% | 20.0% | 0.0% | 0.0% | 4.0% |
放射線療法 | 0.0% | 14.3% | 0.0% | 20.0% | 0.0% | 0.0% | 4.0% |
化学療法 | 37.0% | 28.6% | 66.7% | 100.0% | 0.0% | 0.0% | 44.0% |
TAE | 44.4% | 14.3% | 0.0% | 0.0% | 0.0% | 0.0% | 26.0% |
PEIT | 3.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.0% |
レーザー等治療 | 18.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 10.0% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 84.8% | 66.7% | 22.5% | 6.7% | 90.0% | 0.0% | 49.4% |
手術 | 84.8% | 66.7% | 22.5% | 4.4% | 90.0% | 0.0% | 48.9% |
(うち、体腔鏡的治療) | 78.8% | 53.3% | 17.5% | 0.0% | 80.0% | 0.0% | 42.6% |
内視鏡的治療 | 0.0% | 0.0% | 0.0% | 2.2% | 0.0% | 0.0% | 0.6% |
放射線療法 | 15.2% | 13.3% | 60.0% | 24.4% | 10.0% | 0.0% | 27.3% |
化学療法 | 4.5% | 33.3% | 67.5% | 57.8% | 30.0% | 0.0% | 36.4% |
レーザー等治療 | 1.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.6% |
その他 | 0.0% | 0.0% | 0.0% | 4.4% | 0.0% | 0.0% | 1.1% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術の割合 | 100.0% | 92.6% | 100.0% | 64.7% | 0.0% | 100.0% | 0.0% | 81.3% |
放射線療法 | 28.0% | 44.4% | 48.1% | 35.3% | 35.3% | 50.0% | 0.0% | 40.3% |
化学療法 | 4.0% | 29.6% | 51.9% | 82.4% | 64.7% | 0.0% | 0.0% | 38.9% |
内分泌療法 | 40.0% | 59.3% | 44.4% | 29.4% | 41.2% | 25.0% | 0.0% | 46.5% |
(重複あり)